Echocardiographic findings following renal sympathetic denervation for treatment resistant hypertension, the ReShape CV-risk study

Схожие документы

• Kidney function and markers of renal damage after renal denervation. Does method of measurement matter? The Reshape CV‐Risk Study
  по: Marit D. Solbu, и др.
  Опубликовано: (2021-05-01)
• Thirty‐six‐month results of laparoscopic‐based renal denervation plus unilateral laparoscopic adrenalectomy for the treatment of patients with resistant hypertension caused by unilateral aldosterone‐producing adenoma
  по: Yahui Liu, и др.
  Опубликовано: (2021-05-01)
• Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements
  по: Alexander Vogt, и др.
  Опубликовано: (2023-06-01)
• A Perspective on the Delivery of Renal Denervation Therapy Based on Pre-Clinical Data
  по: Armando Tellez, MD, и др.
  Опубликовано: (2016-06-01)
• Effects of Renal Denervation on Sympathetic Activation, Blood Pressure and Glucose Metabolism in Patients with Resistant Hypertension
  по: Markus Peter Schlaich, и др.
  Опубликовано: (2012-02-01)